Replies to post #16252 on Cytodyn Inc (CYDY)

[Mammit6000]

Thanks for the breakdown. I am holding off on voting to see if any news will come out. I am hoping something comes out this upcoming week with some encouraging news. Even if a dilution does happen it will be a good buying opportunity, however I hope something good comes out of this and it isn't the same story over and over again.

[penniestodimes]

I've been burned by an RS a couple times, so for me, there's no way I can vote for it. In both cases I decided to hold through the RS and within one month I was down over 75% of my original investment. If they do decide to RS, I'll sell before and hope to get back in after. I know it's risky but I'm not losing on a RS again.

I hope with good news and data, we can get the SP up organically. I don't think one PR can do it though. IMO we need at a minimum two PR's within a couple weeks to get this up where we need it.

The next few weeks will be very telling. Good luck to us all

[gestalt2]

I'm really torn over this RS situation. I want to give all the tools necessary to mgmt to get to the goal line but i also am concerned about the increased risk. Let's be honest, mgmt has not really been the most confidence inspiring in controlling and understanding the SP. Too many times good news does not move the SP up and dilution and delayed milestones have damaged the SP. The cost to uplist and increased risk of not holding a SP because of a big raise makes me want them to focus on partnering or even better get bought out.

I have a hard time understanding how the SP is where it is given where pro 140 is in development, what ever is holding it back is not resolved and i'm not so sure being on the OTC has been proven to be the reason.

On the other hand if being on the OTC is capping any SP growth then great, we have a solution. If an uplist does correctly value this company and put CYDY on the radar then that would be great. I would like it if mgmt would do a better job of showing us what and why of this to show some confidence in there understanding of a publicly traded company.